FULGENT GENETICS, INC. (FLGT)

Every figure this model derived for FLGT, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 20,090,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 257,032,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 454,770,000 AssetsCurrent 2026-06-30
current liabilities 71,756,000 LiabilitiesCurrent 2026-06-30
equity 1,001,619,000 StockholdersEquity 2026-06-30
interest expense 120,000 InterestExpenseNonoperating 2026-06-30
ocf -83,697,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 323,932,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 37,507,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up FLGT on one particular measure came for.

RatioValue
cash operating margin-18.2
current ratio6.65
current ratio reported6.34
deferred revenue growth27.35
dilution pct1.79
fcf margin-32.04
growth cv5.91
interest cover-1019.02
operating margin-37.75
owner earnings margin-43.62
revenue growth6.83
revenue growth per share4.95
roic-12.96
rule of 40-30.92
sbc pct revenue11.58

What to be careful about

What this model itself distrusts about FLGT's figures. Written by the derivation as it ran, not added afterwards.